IO Therapeutics Inc logo

IO Therapeutics Inc

Io Therapeutics is a pharma company, focused on developing small molecule therapeutics for the treatment of CNS, cancer and autoimmune diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.io-therapeutics.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
CA 092705-5851
Santa Ana
United States
Email
Contact Number
+1 650-219-5973

In Feb 2013, Io Therapeutics entered into collaboration with the Michael J. Fox Foundation for Parkinsons Research (MJFF) for the evaluation of IRX4204 as a potential treatment for Parkinsons disease.

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/io-therapeutics” connections=”true” suffix=””]

In Aug 2015, Io Therapeutics received funding from National Multiple Sclerosis Society through Fast Forward to support further evaluation of IRX4204 as potential treatment to stimulate repair of myelin, which is damaged in Multiple Sclerosis.